Oxford Nanopore Technologies promethION 2 integrated long-read sequencer

PresolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in BETHESDA, MD
  • Industry: Research and Development in Nanotechnology
  • Advance notice of upcoming solicitation

Contract Details

Notice ID
75N98026Q00877OXFORDNANOTECHNOLOGIESLTD
Opportunity Type
Presolicitation
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
Posted Date
Monday, July 27, 2026
Response Deadline
Wednesday, August 5, 2026
PSC Code
6505
Set-Aside
No Set Aside
Place of Performance
BETHESDA, MD, 20892
Status
Active

Description

OXFORD NANOPRORE TECHNOLOGIES PROMETHOION 2 INTEGRATION LONG-READ SEQUENCER. THIS PURCHASE IS FOR A PROMETHION 2 INTEGRATED LONG-READ SEQUENCER. THIS LONG READ SEQUENCING PROVIDES MORE INFORMATIVE READS THATN STANDARD NEXT-GENERATION SEQUENCING AND ALLOWS FOR BOTH WHOEL GENOME/TRANSCRIPTOME SEQUENCING AND BASE-CALL MODIFICATIONS AT THE SAME TIME. THIS PRODUCT ENABLES HIGH IMPACT AND REAL TIME MULTI OMICS INTEGRATION NOT FOUND IN OTHER SEQUENCING TECHNOLOGIES.

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in nanotechnology with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.